Inteliview
Log inSign up
IPO Tracker
N

Neucleus Group Ltd

Neucleus Group Ltd

USPricing
Valuation$26M
Original Target2026-05-22 (Date under review)
Sector--
Exchange--
RELATED IPOS
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
I
Iron Dome Acquisition I Corp.Iron Dome Acquisition I Corp.US · --
A
Aperture ACAperture ACUS · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
Solidion Technology Inc.
Solidion Technology Inc.Solidion Technology Inc.US · --
FAQ

When is the Neucleus Group Ltd IPO expected?

The Neucleus Group Ltd IPO is currently in the Pricing stage. The originally expected date was 2026-05-22 and the process is ongoing. Timelines may change based on market conditions.

What is Neucleus Group Ltd's valuation?

Neucleus Group Ltd's estimated valuation is approximately $26M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Neucleus Group Ltd IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.